Loading...
| Name | Option type | Quality (1-5)↓ | Topics | Created | |
|---|---|---|---|---|---|
FDA approval of VX-880 by end of 2024?  | Binary | 5 | 6 months ago | ||
Phase 3 trial for VX-880 begins by mid-2025? | Binary | 5 | 6 months ago | ||
Vertex stock price increases by 20% by end of 2024? | Binary | 5 | 6 months ago | ||
Number of patients achieving insulin independence in VX-880 study? | Categorical | 5 | 6 months ago | ||
Vertex Pharmaceuticals market share increase in diabetes treatment by end of 2025? | Categorical | 5 | 6 months ago | ||
Outcomes of VX-880 Phase 1/2 study endpoints? | Categorical | 4 | 6 months ago |